Our Science – Schlom Website
Jeffrey Schlom, Ph.D.
Selected Publications |
 |
| 1)
Huang J, Jochems C, Anderson AA, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J. Soluble CD27-pool in humans may contribute to T-cell activation and tumor immunity. J Immunol. 2013. In Press. [Journal] |
|
| 2)
Campbell CT, Gulley JL, Oyelaran O, Hodge JW, Schlom J, Gildersleeve JC. Serum Antibodies to Blood Group A Predict Survival on PROSTVAC-VF. Clin. Cancer Res. 19: 1290-9, 2013. [Journal] |
|
| 3)
Schlom J, Jochems C, Gulley JL, Huang J. The role of soluble CD40L in immunosuppression. Oncoimmunology. 2: e22546, 2013. [Journal] |
|
| 4)
Huen N, Pang AL, Tucker JA, Lee T, Vergati M, Jochems C, Intrivici C, Cereda V, Chan W, Rennert OM, Madan RA, Gulley JL, Schlom J, Tsang KY. Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer. Int. J. Cancer. [Epub ahead of print], 2013. [Journal] |
|
| 5)
Bot A, Ahn M, Bosch M, Brockstedt D, Butterfield LH, Cornforth A, Harrop R, Kast WM, Koya R, Marincola F, Margolin K, McCoy C, Pawelec G, Rothman J, Ramirez-Montagut T, Schlom J, Srivastava P, Wallis S, Walter S, Wang E, Waslif J. A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies. J Transl Med. 10: 218, 2012. [Journal] |
|
| 6)
Roselli M, Fernando RI, Guadagni F, Spila A, Alessandroni J, Palmirotta R, Costarelli L, Litzinger M, Hamilton DH, Huang B, Tucker JA, Tsang KY, Schlom J, Palena C. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin Cancer Res. 18: 3868-79, 2012. [Journal] |
|
| 7)
Madan RA, Bilusic M, Heery C, Schlom J, Gulley JL. Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines. Semin. Oncol. 39: 296-304, 2012. [Journal] |
|
| 8)
Takai S, Sabzevari H, Farsaci B, Schlom J, Greiner JW. Distinct Effects of Saracatinib on Memory CD8+ T Cell Differentiation. J. Immunol. 188: 4323-33, 2012. [Journal] |
|
| 9)
Huang J, Jochems C, Talaie T, Anderson A, Jales A, Tsang KY, Madan RA, Gulley JL, Schlom J. Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role. Blood. 120: 3030-8, 2012. [Journal] |
|
| 10)
Schlom J, Hodge JW. Introduction: therapeutic cancer vaccines. Semin. Oncol. 39: 243-4, 2012. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/30/2013.
